These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33551769)

  • 21. Total Absence of Dystrophin Expression Exacerbates Ectopic Myofiber Calcification and Fibrosis and Alters Macrophage Infiltration Patterns.
    Young CNJ; Gosselin MRF; Rumney R; Oksiejuk A; Chira N; Bozycki L; Matryba P; Łukasiewicz K; Kao AP; Dunlop J; Robson SC; Zabłocki K; Górecki DC
    Am J Pathol; 2020 Jan; 190(1):190-205. PubMed ID: 31726040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse.
    Vaillend C; Billard JM; Laroche S
    Neurobiol Dis; 2004 Oct; 17(1):10-20. PubMed ID: 15350961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras.
    Gonzalez JP; Kyrychenko S; Kyrychenko V; Schneider JS; Granier CJ; Himelman E; Lahey KC; Zhao Q; Yehia G; Tao YX; Bhaumik M; Shirokova N; Fraidenraich D
    Stem Cells; 2017 Mar; 35(3):597-610. PubMed ID: 27734557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.
    Xu S; Shi D; Pratt SJP; Zhu W; Marshall A; Lovering RM
    Neuromuscul Disord; 2015 Oct; 25(10):764-72. PubMed ID: 26236031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks.
    Vaillend C; Rendon A; Misslin R; Ungerer A
    Behav Genet; 1995 Nov; 25(6):569-79. PubMed ID: 8540895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
    Rafael JA; Nitta Y; Peters J; Davies KE
    Mamm Genome; 2000 Sep; 11(9):725-8. PubMed ID: 10967129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
    Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
    PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products.
    Vaillend C; Billard JM; Claudepierre T; Rendon A; Dutar P; Ungerer A
    Neuroscience; 1998 Sep; 86(1):53-66. PubMed ID: 9692743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.
    Stedman HH; Sweeney HL; Shrager JB; Maguire HC; Panettieri RA; Petrof B; Narusawa M; Leferovich JM; Sladky JT; Kelly AM
    Nature; 1991 Aug; 352(6335):536-9. PubMed ID: 1865908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
    Bonuccelli G; Sotgia F; Capozza F; Gazzerro E; Minetti C; Lisanti MP
    Cell Cycle; 2007 May; 6(10):1242-8. PubMed ID: 17495527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive avoidance behaviour deficit in the mdx mouse.
    Muntoni F; Mateddu A; Serra G
    Neuromuscul Disord; 1991; 1(2):121-3. PubMed ID: 1822782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse.
    Kueh SL; Dempster J; Head SI; Morley JW
    Neurobiol Dis; 2011 Sep; 43(3):558-64. PubMed ID: 21601636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model.
    Yavas A; Weij R; van Putten M; Kourkouta E; Beekman C; Puoliväli J; Bragge T; Ahtoniemi T; Knijnenburg J; Hoogenboom ME; Ariyurek Y; Aartsma-Rus A; van Deutekom J; Datson N
    PLoS One; 2020; 15(12):e0244215. PubMed ID: 33362201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.